Marker Therapeutics (GX1) Revenue

1 Followers

Marker Therapeutics Revenue

Marker Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 1.23M, Increased -41.12%. In the fiscal year ending Dec 31, 2025, Marker Therapeutics had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

1.23M

Revenue Growth

-59.58%

P/S Ratio

―

Revenue/Employee

€0

Employees

Market Cap

€15.55M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-6.59M	-100.00%
Mar 31, 2025	6.59M	3.28M	+99.06%
Dec 31, 2023	3.31M	-202.41K	-5.76%
Dec 31, 2022	3.51M	2.27M	+182.96%
Dec 31, 2021	1.24M	774.92K	+166.01%
Dec 31, 2020	466.79K	253.59K	+118.95%
Dec 31, 2019	213.19K	7.20K	+3.50%
Dec 31, 2018	205.99K	22.93K	+12.53%
Dec 31, 2017	183.06K	―	―